These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37828513)

  • 21. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
    Jablonska E; Marcinczyk M
    Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
    Dovio A; Perazzolo L; Saba L; Termine A; Capobianco M; Bertolotto A; Angeli A
    Eur J Endocrinol; 2006 May; 154(5):745-51. PubMed ID: 16645023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Viscum album extract therapy in patients with cancer: relation with interleukin-6, soluble interleukin-6 receptor, and soluble gp130.
    Kovacs E
    J Altern Complement Med; 2004 Apr; 10(2):241-6. PubMed ID: 15165404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.
    Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G
    Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of systemic IL-6 trans-signalling in patients with primary open-angle glaucoma.
    Ulhaq ZS; Istifiani LA; Pamungkas SA
    J Fr Ophtalmol; 2023 Jun; 46(6):622-629. PubMed ID: 37095023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes.
    Kuźmicki M; Telejko B; Lipińska D; Pliszka J; Wilk J; Wawrusiewicz-Kurylonek N; Zielińska A; Sobota A; Krętowski A; Górska M; Szamatowicz J
    Endokrynol Pol; 2014; 65(3):169-75. PubMed ID: 24971916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
    Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
    J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis.
    Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV
    Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
    Shang J; Xu Y; Zhang H
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):87-8. PubMed ID: 10861111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia.
    Zhao S; Gu Y; Dong Q; Fan R; Wang Y
    Placenta; 2008 Dec; 29(12):1024-8. PubMed ID: 18986700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
    Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H
    J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses.
    Wang Y; Gu Y; Alexander JS; Lewis DF
    Pathophysiology; 2021 Apr; 28(2):202-211. PubMed ID: 35366257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.
    Narazaki M; Yasukawa K; Saito T; Ohsugi Y; Fukui H; Koishihara Y; Yancopoulos GD; Taga T; Kishimoto T
    Blood; 1993 Aug; 82(4):1120-6. PubMed ID: 8353278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
    Pulsatelli L; Boiardi L; Pignotti E; Dolzani P; Silvestri T; Macchioni P; Cantini F; Salvarani C; Facchini A; Meliconi R
    Arthritis Rheum; 2008 Aug; 59(8):1147-54. PubMed ID: 18668607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases.
    Doré P; Lelièvre E; Morel F; Brizard A; Fourcin M; Clemént C; Ingrand P; Daneski L; Gascan H; Wijdenes J; Gombert J; Preud'homme JL; Lecron JC
    Clin Exp Immunol; 1997 Jan; 107(1):182-8. PubMed ID: 9010274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.